- $1.01bn
- $1.35bn
- $1.78bn
- 78
- 54
- 62
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,664 | 1,087 | 1,177 | 1,554 | 1,782 |
Cost of Revenue | |||||
Gross Profit | 228 | 128 | 185 | 226 | 254 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,574 | 1,307 | 1,111 | 1,471 | 1,705 |
Operating Profit | 89.7 | -220 | 66.5 | 82.9 | 77.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 71.1 | -240 | 45.8 | 65.6 | 48.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 51.7 | -173 | 35.3 | 48.1 | 34.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 48.8 | -173 | 31.7 | 45.2 | 31.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 48.8 | -173 | 31.7 | 45.2 | 31.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.24 | -0.748 | 1.73 | 2.41 | 2.22 |